Work

Prevalence, Predictors, and Economic Impact of Drug-Drug Interaction Associated with Antipsychotic Medications among Adults in United States

Year: 2017
Type: article
Abstract: BackgroundAlthough antipsychotics can relieve or prevent many psychotic disorders, it also has risks.They are subject to drug-drug interactions (DDIs) amongst themselves and with other agents used in the treatment of various physical conditions.Given the significant clinical effect of DDIs with antipsychotics on patient's health and potential economic impact of DDIs on healthcare expenditure, little information is available about the prevalence, risk factors, and cost of DDIs with antipsychotics and is based on small studies with uncertain generalizability. Research PurposesThe purposes of this research were, first, to develop a list of clinically important DDIs likely to be encountered by U.S. adult population who treated with any antipsychotics and then determine the prevalence and identify predictors of DDIs.The last purpose of this study is to investigate the relationship between the health expenditures and DDIs. MethodsIn this research, I first conducted a systemic review of four compendia and published literature to identify all potential important DDIs.Then, the list was reviewed and approved by a panel of experts to be used as criteria in our analyses.A retrospective database analysis was conducted, and individuals who were exposed to any DDI were identified from the 2010-2014 Medical Expenditure Panel Survey (MEPS).The prevalence of DDI was evaluated using the developed list of clinically important DDIs.Next, I developed a theoretical framework based on Anderson Behavioral Model to test relationships among the latent constructs of predisposing characteristics, enabling resources, and need for healthcare, health behaviors, and medication use
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W2651117223
FWCI:
Cites: 143
Cited by:
Related to: 10